Gilenya and Restless leg syndrome - a phase IV clinical study of FDA data
Restless leg syndrome is found among people who take Gilenya, especially for people who are female, 50-59 old, have been taking the drug for 6 - 12 months.
The phase IV clinical study analyzes which people take Gilenya and have Restless leg syndrome. It is created by eHealthMe based on reports of 101,877 people who have side effects when taking Gilenya from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
101,877 people reported to have side effects when taking Gilenya.
Among them, 266 people (0.26%) have Restless leg syndrome.
What is Gilenya?
Gilenya has active ingredients of fingolimod. It is often used in multiple sclerosis. eHealthMe is studying from 107,195 Gilenya users for its effectiveness, alternative drugs and more.
What is Restless leg syndrome?
Restless leg syndrome (a powerful urge to move your legs) is found to be associated with 2,345 drugs and 1,756 conditions by eHealthMe.
Number of Gilenya and Restless leg syndrome reports submitted per year:
Time on Gilenya when people have Restless leg syndrome *:
Gender of people who have Restless leg syndrome when taking Gilenya*:
Age of people who have Restless leg syndrome when taking Gilenya *:
Common drugs people take besides Gilenya *:
Common side effects people have besides Restless leg syndrome *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gilenya and have Restless leg syndrome?Check whether Restless leg syndrome is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Alroughani R, "Fingolimod-associated amenorrhea: a report of three cases", Multiple Sclerosis Journal, 2014 Jan .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
How severe was Restless leg syndrome and when was it recovered:
Expand to all the drugs that have ingredients of fingolimod:
Alternative drugs to, pros and cons of Gilenya:
- Gilenya (107,195 reports)
Common Gilenya side effects:
Browse all side effects of Gilenya:a b c d e f g h i j k l m n o p q r s t u v w x y z
Restless leg syndrome treatments and more:
- Restless leg syndrome (44,796 reports)
COVID vaccines that are related to Restless leg syndrome:
- Restless leg syndrome in Moderna COVID Vaccine
- Restless leg syndrome in Pfizer BioNTech Covid Vaccine
- Restless leg syndrome in Johnson and Johnson Covid Vaccine
Common drugs associated with Restless leg syndrome:
All the drugs that are associated with Restless leg syndrome:
- Restless leg syndrome (2,345 drugs)
Common conditions associated with Restless leg syndrome:
All the conditions that are associated with Restless leg syndrome:
- Restless leg syndrome (1,756 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fingolimod (the active ingredients of Gilenya) and Gilenya (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Famotidine and Oedema Lower Limb - a second ago
- Ondansetron Hydrochloride and Viith Nerve Paralysis - 4 seconds ago
- Ketamine Hcl and Liver Injury - 10 seconds ago
- Remicade and Curvature Of The Penis - 16 seconds ago
- Sofosbuvir and Sirolimus drug interaction - 24 seconds ago
- Innohep and Anuria - 25 seconds ago
- Tylenol and Ultrasound Doppler Abnormal - 27 seconds ago
- Carbidopa And Levodopa and Radiculopathy - 27 seconds ago
- Zosyn and Peripheral Sensory Neuropathy - 27 seconds ago
- Diflucan and Anaemia Neonatal - 36 seconds ago